Double Bond Pharmaceutical International
0,11
SEK
+2,33 %
Mindre end 1K følgere
DBP B
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
Double Bond Pharmaceutical, DBP, is a pharmaceutical company. The main focus is on the treatment of severe forms of cancer, infections and autoimmune diseases. The research is based on the company's proprietary technology. The products are sold under separate trademarks and collaboration on product development is done together with other players in the field. The company is based in Uppsala.
Læs mereMarkedsværdi
27,49 mio. SEK
Aktieomsætning
20,7 t SEK
Omsætning
1,09 mio.
EBIT %
-711,93 %
P/E
-
Udbytteafkast, %
-
Finanskalender
23.6
2025
Generalforsamling '25
26.8
2025
Delårsrapport Q2'25
25.11
2025
Delårsrapport Q3'25
Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools